IUIS relationship with the World Health Organization

September 15, 2017

 

IUIS has long had an informal relationship with the World Health Organisation (WHO). In 2017, this relationship was formalized according to WHO guidelines. The goal of the collaboration is to advance WHO’s work on quality, safety and efficacy of medical biological products with IUIS providing relevant expert immunology knowledge. Our new relationship involves planned contributions from IUIS and its members.

Specifically, we will work together on the WHO Programme Area: access to medicines and health technologies and strengthening regulatory capacity.

 

IUIS will provide support and knowledge in determining norms and standards for biologicals, especially vaccines, and scientific input on nomenclature of immunology molecules. We also support educational activities and communication to strengthen expertise in immunology.

 

We are grateful to Ivana Knezevic, who is our WHO liaison and has helped us immensely in creating this collaboration. We look forward to some exciting outcomes in the next three years.

More News

EFIS Travel Grants for ALACI 2024

June 19, 2024European Federation of Immunological Societies (EFIS)

Travel4Expertise – The Grant for Caregivers

May 17, 2024Gender Equity Committee (GEC)

HOST AN IN-PERSON
IUIS IMMUNOLOGY
COURSE IN 2025

May 8, 2024Education Committee (EDU)

Michelson Prizes: Next Generation Grant

April 30, 2024Early Career Committee (ECC)

IUIS Junior Community: Pushing the Frontiers of Immunology

April 19, 2024Early Career Committee (ECC)

2024 Day of Immunology Webinar registration is live!

March 15, 2024

Call for Applications to join the IUIS Gender Equity Committee

March 1, 2024Gender Equity Committee (GEC)

IUIS/AAI AWARDS: SUMMER COURSES in IMMUNOLOGY

February 8, 2024American Association of Immunologists (AAI), Gender Equity Committee (GEC) and 1 more

Calling for Nominations to the EDU Committee & its online subcommittee

November 7, 2023Education Committee (EDU)